Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Smart Pills Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Smart Pills Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Smart Pills Market: Application Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Smart Pills Market: Application Movement Analysis, 2023 & 2030 (USD Million)
4.3. Capsule Endoscopy
4.3.1. Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Drug Delivery
4.4.1. Drug Delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Vital Sign Monitoring
4.5.1. Vital Sign Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Smart Pills Market: Disease Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Smart Pills Market: Disease Indication Movement Analysis, 2023 & 2030 (USD Million)
5.3. Occult GI Bleeding
5.3.1. Occult GI Bleeding Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Crohn’s Disease
5.4.1. Crohn’s Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Small Bowel Tumors
5.5.1. Small Bowel Tumors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Celiac Disease
5.6.1. Celiac Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Inherited Polyposis Syndromes
5.7.1. Inherited Polyposis Syndromes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Neurological Disorders
5.8.1. Neurological disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Other Disease Indications
5.9.1. Other Disease Indications Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Smart Pills Market: Target Area Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Smart Pills Market: Target Area Movement Analysis, 2023 & 2030 (USD Million)
6.3. Esophagus
6.3.1. Esophagus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Small Intestine
6.4.1. Small Intestine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Large Intestine
6.5.1. Large Intestine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Stomach
6.6.1. Stomach Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Smart Pills Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Smart Pills Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
7.3. Hospitals
7.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Outpatient Facilities
7.4.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Smart Pills Market: Regional Estimates & Trend Analysis
8.1. Smart Pills Market Share, By Region, 2023 & 2030 (USD Million)
8.2. North America
8.2.1. North America Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. UK Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. France Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.3. China
8.4.3.1. China Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.4. India
8.4.4.1. India Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. Saudi Arabia Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE Smart Pills Market Estimates and Forecasts, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait Smart Pills Market Estimates and Forecasts, 2018 - 2030) (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Medtronic
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Otsuka Holdings Co., Ltd.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Olympus Corporation
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. CapsoCam Plus
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Pentax Medical
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. JINSHAN Science & Technology (Group) Co., Ltd.
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Check-Cap Ltd.
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. etectRx
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. INTROMEDIC
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. Shenzen Jifu Medical Technology Co., Ltd
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
9.4.11. BodyCapUSA
9.4.11.1. Participant’s Overview
9.4.11.2. Financial Performance
9.4.11.3. Product Benchmarking
9.4.11.4. Recent Developments/ Strategic Initiatives